MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer

Figure 1

Expression of hsa-miR-195-5p in lung cancer patients, COPD patients, and normal controls. All datasets show higher expression of hsa-miR-195-5p in lung cancer and COPD patients compared with normal controls. Because of the absence of samples, some datasets do not contain all three population types.